Asset Allocation & Management Company, LLC Gilead Sciences, Inc. Transaction History

Asset Allocation & Management Company, LLC

$159 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $90,052 - $129,284	-1,445 Reduced 27.53%	3,803 $326,000
Q2 2022 Jul 19, 2022	SELL	$57.72 - $65.01 $454,371 - $511,758	-7,872 Reduced 60.0%	5,248 $324,000
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $851,225 - $966,156	13,120 New	13,120 $953,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Allocation & Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Allocation & Management Company, LLC with notifications on news.

Account